bpc-157 inflammatory bowel disease human study as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Pentadecapeptide BPC 157, in Clinical

Description

Not for human use, veterinary use, or ingestion of any kind

By influencing these pathways, BPC-157 is studied for its potential impact on circulation and tissue support mechanisms

Managing diabetic foot ulcers is rarely about the ulcer alone

This peptide stack is designed to accelerate that timeline

PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 62 H 98 N 16 O 22 Weight: 1,419.53 g/mol CAS: 137525-51-0 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily dissolves in water Stability: Stable across various pH conditions Storage: Keep refrigerated 3646 F (28 C) Related products Epithalon $45.00 $140.00Price range: $45.00 through $140.00